Loading market dashboard
Cardiol Therapeutics Inc.
CRDL.TOHealthcareTSXCA
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Cardiol Therapeutics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $196.43M | $196.43M - $196.43M | $117.86M | $0.873 | 3 |
| Dec 2029 | $97.87M | $97.87M - $97.87M | $58.72M | $0.32 | 3 |
| Dec 2028 | $48.43M | $48.43M - $48.43M | $29.06M | $0.047 | 4 |
| Dec 2027 | $4.15M | $4.15M - $4.15M | $2.49M | -$0.225 | 5 |
| Dec 2026 | $1.50M | $1.50M - $1.50M | $902.0K | -$0.474 | 4 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.464 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.594 | 0 |
| Dec 2021 | $567.0K | $567.0K - $567.0K | $340.2K | -$0.51 | 1 |